SAN FRANCISCO, CA – FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company currently valued at $33.1 million, announced today that it has amended agreements with Fortis (NYSE:FTS ...

Fortis Healthcare Ltd share price was down by -0.93% from the previous closing price of ₹645.70. Who are peers of Fortis Healthcare Ltd? The peers of Fortis Healthcare Ltd are Max Healthcare ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Q: What is the Dollar worth against the Nigerian Naira? A: One Dollar is worth 1522.9348 Nigerian Naira today Q: Is the Dollar going up or down against the Nigerian Naira? A: Today's exchange rate ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

The Sultan of Sokoto and President General Supreme Council for Islamic Affairs in Nigeria, Muhammad Sa’ad Abubakar III has announced the sighting of the new moon of Shawwal 1446 AH.

The Company’s valves have been exported to Kuwait, Nigeria, and Malaysia. The Company's factory is located in Kudus, Palghar.

www.TheLFB-Forex.com The Forex Trader PortalCurrent Futures: Dow +1.00, S&P +0.80, NASDAQ +3.00European markets opened higher as ...

Rights Aug 18, 2009 Aug 20, 2009 Dec 24, 2008 Rights ratio: 2 share for every 5 held at a price of Rs 110.0 Rights-Aug 20, 2009 Aug 10, 2009 Rights ratio: 2 share for every 5 held at a price of Rs 110 ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

SAN FRANCISCO, CA – FibroGen, Inc. (NASDAQ:FGEN), a biopharmaceutical company currently valued at $33.1 million, announced today that it has amended agreements with Fortis (NYSE:FTS) Therapeutics, Inc ...